158.2 [MA158.2]
158.2 [MA158.2]
规格:
货期:
编号:TS213031
品牌:Testobio
| 产品名称： | 158.2 MA158.2 |
|---|---|
| 商品货号： | TS213031 |
| Organism： | Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts weakly with resident mouse peritoneal macrophages and strongly with mouse macrophages that have been activated by treatment with Macrophage Activating Factor (MAF) or thioglycollate. The antigen is not related to Mac-1, Mac-2 or Mac-3 and does not appear to be strain or sex specific. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against activated mouse macrophages |
| Cellular Products： | immunoglobulin; monoclonal antibody; against activated mouse macrophages |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in nude mice |
| Comments： | Animals were immunized with activated mouse macrophages. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts weakly with resident mouse peritoneal macrophages and strongly with mouse macrophages that have been activated by treatment with Macrophage Activating Factor (MAF) or thioglycollate. It does not react with rat macrophages nor with a panel of mouse macrophage, monocyte or lymphoid cell lines. The antigen is not related to Mac-1, Mac-2 or Mac-3 and does not appear to be strain or sex specific. The antigen is not trypsin sensitive. |
| Complete Growth Medium： | The base medium for this cell line is ATCC Hybri-Care Medium, Catalog No. 46-X. Hybri-Care Medium is supplied as a powder and should be reconstituted in 1 L cell-culture-grade water and supplemented with 1.5 g/L sodium bicarbonate. To make the complete growth medium, add the following components to the base medium: heat-inactivated bovine calf serum to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG2a |
| Name of Depositor： | SmithKline Beckman Corporation |
| Deposited As： | rat (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Koestler TP. Monoclonal antibody to activated macrophages. US Patent 4,701,408 dated Oct 20 1987 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
158.2 [MA158.2]
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 158.2 MA158.2 |
|---|---|
| 商品货号： | TS213031 |
| Organism： | Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts weakly with resident mouse peritoneal macrophages and strongly with mouse macrophages that have been activated by treatment with Macrophage Activating Factor (MAF) or thioglycollate. The antigen is not related to Mac-1, Mac-2 or Mac-3 and does not appear to be strain or sex specific. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against activated mouse macrophages |
| Cellular Products： | immunoglobulin; monoclonal antibody; against activated mouse macrophages |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in nude mice |
| Comments： | Animals were immunized with activated mouse macrophages. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts weakly with resident mouse peritoneal macrophages and strongly with mouse macrophages that have been activated by treatment with Macrophage Activating Factor (MAF) or thioglycollate. It does not react with rat macrophages nor with a panel of mouse macrophage, monocyte or lymphoid cell lines. The antigen is not related to Mac-1, Mac-2 or Mac-3 and does not appear to be strain or sex specific. The antigen is not trypsin sensitive. |
| Complete Growth Medium： | The base medium for this cell line is ATCC Hybri-Care Medium, Catalog No. 46-X. Hybri-Care Medium is supplied as a powder and should be reconstituted in 1 L cell-culture-grade water and supplemented with 1.5 g/L sodium bicarbonate. To make the complete growth medium, add the following components to the base medium: heat-inactivated bovine calf serum to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG2a |
| Name of Depositor： | SmithKline Beckman Corporation |
| Deposited As： | rat (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Koestler TP. Monoclonal antibody to activated macrophages. US Patent 4,701,408 dated Oct 20 1987 |
